Dr. Maria (Marianna) Dalamaga, Clinical Pathologist, is currently Associate Professor of Biological Chemistry-Clinical Biochemistry at the National and Kapodistrian University of Athens (NKUA), School of Medicine. Dr Dalamaga graduated with high distinction from the University of Ioannina Medical School, received a Master’s degree in Epidemiology from Harvard University School of Public Health and a Master’s degree in Public Health from the National School of Public Health in Athens. She obtained a PhD degree from the NKUA School of Medicine in cooperation with the Hellenic Pasteur Institute. Dr Dalamaga completed her residency in Medical Biopathology (Clinical Pathology)/Laboratory Medicine at NIMTS and Evangelismos General Hospitals with a fellowship in Clinical Biochemistry awarded from the European Board of Medical Biopathology, Union of European Medical Specialists. She is the recipient of 35 Greek & International awards including the First Class Award in Science from the Athens Academy. She is editorial board member, Associate Editor and Section Editor of several prestigious international peer-reviewed journals, being recently appointed as Editor-in-Chief of Metabolism Open, Elsevier editions. She currently serves as Vice-President of the Hellenic Society of Medical Biochemistry. She has co-authored more than 180 peer-reviewed articles in international journals and supplements, and 24 monographs, books and chapter books. She has been an Invited Speaker in >100 Conferences. Her research interests focus on biomarkers, metabolism and obesity. She is married and has two children.
Dr Dalamaga will be visiting the renowned Ocular Regenerative Medicine Institute, Mass Eye and Ear, Massachusetts General Hospital, Harvard Medical School (HMS) in Boston, MA and will be involved in a longitudinal ongoing research project entitled “Understanding systemic Lipids in the pathogenesis of Age-related Macular Degeneration: an omics approach”. This is an innovative project in translational and laboratory research combining cutting-edge approaches (metabolomics and genomics) and advanced statistical and bioinformatics tools (machine learning approaches). These system-based approaches can unravel disease-related processes that are valuable for biomarker discovery usable for screening, diagnosis, stratification of patients, prognosis and treatment response prediction as well as personalized patient care.
Upon her return, Dr. Dalamaga aims to strengthen the collaboration between HMS and Greek research groups as well as to share the acquired knowledge and experience with her colleagues, students and residents. Dr. Dalamaga will strongly encourage her medical students and residents to pursue similar opportunities and broaden their own scientific and professional horizons.